Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2011
08/04/2011WO2011028947A3 Heterocyclic compounds for the inhibition of pask
08/04/2011US20110190501 2, 2-Bipyridine ligand, sensitizing dye and dye sensitized solar cell
08/04/2011US20110190491 S-triazole alpha- mercaptoacetanilides as inhibitors of hiv reverse transcriptase
08/04/2011US20110190486 Sulfonamide derivatives of polycyclic dyes used for analytical applications
08/04/2011US20110190369 Substituted Pyrrole Derivatives and Their Use as HMG-CO Inhibitors
08/04/2011US20110190353 Fungicide hydroximoyl-tetrazole derivatives
08/04/2011US20110190346 Diphenyl Substituted Alkanes as Flap Inhibitors
08/04/2011US20110190344 Benzimidazole modulators of vr1
08/04/2011US20110190343 Hiv-1 fusion inhibitors and methods
08/04/2011US20110190342 Glycine b antagonist
08/04/2011US20110190335 Nitrogenated 5-membered heterocyclic compound
08/04/2011US20110190328 Acid addition salts of (3,5-bis trifluoromethyl)-n-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]-benzamide
08/04/2011US20110190316 Substituted pyridines, and use thereof as Gsk3 inhibitors
08/04/2011US20110190313 Treatment of Pulmonary Arterial Hypertension
08/04/2011US20110190300 Amide compounds and the use thereof
08/04/2011US20110190298 4-phenoxymethylpiperidines as modulators of gpr119 activity
08/04/2011US20110190297 Pyridine and pyrimidine based compounds as wnt signaling pathway inhibitors for the treatment of cancer
08/04/2011US20110190296 Substituted Pyrrole Derivatives and Their Use as HMG-CO Inhibitors
08/04/2011US20110190294 Novel estrogen receptor ligands
08/04/2011US20110190293 Quinazolinone Compounds as Anticancer Agents
08/04/2011US20110190283 Fab I Inhibitors
08/04/2011US20110190279 Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity
08/04/2011US20110190278 Bicyclic heterocyclic derivative
08/04/2011US20110190272 Chemical compounds
08/04/2011US20110190267 Prodrugs of opioids and uses thereof
08/04/2011US20110190262 Aryl-and Heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
08/04/2011US20110190259 Compounds and compositions as protein kinase inhibitors
08/04/2011US20110190258 Aryl benzylamine compounds
08/04/2011US20110190256 Amine and Ether Compounds Which Modulate The CB2 Receptor
08/04/2011US20110189192 Novel compounds that are erk inhibitors
08/04/2011US20110189127 Tricyclic indole derivatives and methods of use thereof
08/04/2011US20110186821 Azapyrenes for electronic applications
08/04/2011DE102010006121A1 Materialien für organische Elektrolumineszenzvorrichtungen Materials for organic electroluminescent
08/04/2011CA2788417A1 Trypsin-like serine protease inhibitors, and their preparation and use
08/04/2011CA2788147A1 Process for the preparation of crystalline forms of dexlansoprazole
08/04/2011CA2788073A1 Di-substituted pyridine derivatives as anticancers
08/04/2011CA2787785A1 Compositions and methods for enhancing proteasome activity
08/04/2011CA2787407A1 5-alkynyl-pyrimidines
08/04/2011CA2787396A1 5-alkynyl pyrimidines and their use as kinase inhibitors
08/04/2011CA2786509A1 Sulfonamido derivatives of 3,4-diarylpyrazoles as protein kinase inhibitors
08/04/2011CA2784571A1 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
08/04/2011CA2770767A1 Bicyclic heteroaryl inhibitors of pde4
08/03/2011EP2351751A1 Substituted pyrazolopyrimidines
08/03/2011EP2351750A1 1,3,5-triazine derivative, process for producing same, and organic electroluminescent element comprising same as constituent component
08/03/2011EP2351749A1 Carbamate compound or salt thereof
08/03/2011EP2351748A1 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient
08/03/2011EP2351745A1 Pyrazine derivatives and use as PI3K inhibitors
08/03/2011EP2351737A1 3-Amino-1-arylpropyl indoles and aza-substituted indoles
08/03/2011EP2350311A1 Diacylglycerol acyltransferase inhibitors
08/03/2011EP2350073A1 3H-IMIDAZO[4,5-b]PYRIDINE-6-CARBOXAMIDES AS ANTI-INFLAMMATORY AGENTS
08/03/2011EP2350066A1 2,5-disubstituted piperidine orexin receptor antagonists
08/03/2011EP2350061A1 2,3-disubstituted piperidine orexin receptor antagonists
08/03/2011EP2350060A2 Melanocortin receptor agonists
08/03/2011EP2350059A2 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
08/03/2011EP2350055A1 Lenalidomide solvates and processes
08/03/2011EP2350054A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
08/03/2011EP2350052A2 Antiproliferative compounds
08/03/2011EP2350051A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
08/03/2011EP2350050A1 Process for the preparation of enantiomerically enriched proton pump inhibitors
08/03/2011EP2350049A2 P38 map kinase inhibitors
08/03/2011EP2350048A2 Azine derivatives and methods of use thereof
08/03/2011EP2350047A2 P38 map kinase inhibitors
08/03/2011EP2350046A1 Method for preparing a non-hydratable crystal form
08/03/2011EP2350045A1 C-met protein kinase inhibitors
08/03/2011EP2350044A1 Method of inducing negative chemotaxis
08/03/2011EP2350020A1 Spiro-imidazolone derivatives as glucagon receptor antagonists
08/03/2011EP2350015A1 Isoquinolinone derivatives as nk3 antagonists
08/03/2011EP2350010A1 Isonicotinamide orexin receptor antagonists
08/03/2011EP2350007A1 Heterocyclic antiviral arylpyridone derivatives
08/03/2011EP2350006A1 Compounds for inflammation and immune-related uses
08/03/2011EP2350004A1 Compounds for inflammation and immune-related uses
08/03/2011EP2350003A1 Substituted disulfonamides as bri-modulators
08/03/2011EP2350002A1 Novel compounds as calcium channel blockers
08/03/2011EP2349995A1 Selective seprase inhibitors
08/03/2011EP2349994A1 Pesticidal (hetero) arylpyrrolidines
08/03/2011EP2349484A2 Heteroaryl derivatives as dgat1 inhibitors
08/03/2011EP2349279A1 Modulators of aldehyde dehydrogenase and methods of use thereof
08/03/2011EP2349273A1 Modulators of cxcr7
08/03/2011EP2349269A1 2,5-disubstituted piperidine orexin receptor antagonists
08/03/2011EP2348856A1 2,4-disubstituted pyrrolidine orexin receptor antagonists
08/03/2011EP2348846A1 Disubstituted azepan orexin receptor antagonists
08/03/2011EP2240458B1 Aryl sulfonamides as effective analgesics
08/03/2011EP2183222B1 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof
08/03/2011EP2155690B1 Indazolamide derivatives
08/03/2011EP2152674B1 Benzimidazolone chymase inhibitors
08/03/2011EP2125782B1 Aryl carboxylic acid cyclohexyl amide derivatives
08/03/2011EP1948638B1 Compounds for the treatment of inflammatory disorders
08/03/2011EP1934198B1 Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor
08/03/2011EP1853587B1 Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity
08/03/2011EP1836172B1 5-ht7 receptor antagonists
08/03/2011EP1794146B1 Tricyclic anilide spirohydantoin cgrp receptor antagonists
08/03/2011CN1964970B Iap的抑制剂 Iap inhibitors
08/03/2011CN1890218B Tubulin inhibitors
08/03/2011CN1849307B Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists
08/03/2011CN102143958A Pyridazine derivatives as SMO inhibitors
08/03/2011CN102143957A Benzimidazoles and related analogs as sirtuin modulators
08/03/2011CN102143956A Derivatives of indole 2-carboxamides and azaindole 2-carboxamides substituted by a silanyle group, preparation thereof and therapeutic use thereof
08/03/2011CN102143955A 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
08/03/2011CN102140104A 1-(3-(S)-amino propyl)-piperidine-4-aminoacid amide compound and pharmaceutical composition thereof as well as preparation methods and applications of compound and pharmaceutical composition
08/03/2011CN102140093A Pyridine amide derivatives, preparation method thereof and application thereof in medicines